A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.
Entrepreneurship Guest Lecture Series
Publication date: Dec 06, 2012 02:11 PM
Start: Dec 06, 2012 05:15 PM
Jon Bradford - CEO and Co-founder, Springboard
Springboard combines investment capital with an intensive 13 week mentor-led accelerator programme.
Whilst the Springboard program is based at Google Campus in London and ideaSpace in Cambridge, it is aimed at ambitious and scalable early stage businesses from both UK and overseas.